Search Results for: CYB5B

55 interactions involving CYB5B - cytochrome b5 type B found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
EBP EBP cholestenol delta-isomerase
  • Cholesterol biosynthesis via desmosterol
  • Cholesterol biosynthesis via lathosterol
  • Tamoxifen
FAM209A family with sequence similarity 209 member A
FAM210B family with sequence similarity 210 member B
FNDC9 fibronectin type III domain containing 9
FRMD3 FERM domain containing 3
GJB5 gap junction protein beta 5
  • Gap junction assembly
GPR152 G protein-coupled receptor 152
IGSF9 immunoglobulin superfamily member 9
KCNK5 potassium two pore domain channel subfamily K member 5
  • Phase 4 - resting membrane potential
KIR2DL3 killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
LMNA lamin A/C
  • XBP1(S) activates chaperone genes
  • Signaling by BRAF and RAF fusions
  • Restrictive dermopathy
  • Emery-Dreifuss muscular dystrophy
  • Dilated cardiomyopathy (DCM)
  • Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
  • Mandibuloacral dysplasia
  • Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
  • Limb-girdle muscular dystrophy (LGMD)
  • Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
  • Hutchinson-Gilford progeria syndrome
MARCHF8 membrane associated ring-CH-type finger 8
MFF mitochondrial fission factor
MFSD14B major facilitator superfamily domain containing 14B
MFSD4B major facilitator superfamily domain containing 4B
  • Cellular hexose transport
MFSD5 major facilitator superfamily domain containing 5
MUC1 mucin 1, cell surface associated
  • Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)
  • Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
  • Defective GALNT12 causes colorectal cancer 1 (CRCS1)
  • Dectin-2 family
  • Interleukin-4 and Interleukin-13 signaling
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
  • TG4010
NDUFAF2 NADH:ubiquinone oxidoreductase complex assembly factor 2
  • Complex I biogenesis
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
PDZK1IP1 PDZK1 interacting protein 1
PHACTR3 phosphatase and actin regulator 3

Page 2 out of 3 pages